| Sign In to gain access to subscriptions and/or personal tools. |
β2-Adrenoceptor Regulation of CGRP Release from Capsaicin-sensitive Neurons
1 Division of Endodontics, University of Minnesota School of Dentistry; Correspondence: *corresponding author, Hargreaves{at}UTHSCSA.edu Previous studies have suggested that neurotransmitter substances from the sympatho-adrenomedullary system regulate pulpal blood flow (PBF), in part, by the inhibition of vasoactive neuropeptide release from pulpal sensory neurons. However, no study has evaluated the role of β-adrenoceptors. We evaluated the hypothesis that activation of β-adrenoceptors inhibits immunoreactive calcitonin gene-related peptide (iCGRP) release from capsaicin-sensitive nociceptive neurons via in vitro superfusion of bovine dental pulp. Either norepinephrine or epinephrine inhibited capsaicin-evoked iCGRP. The norepinephrine effect was blocked by the selective β2-adrenoceptor antagonist, ICI 118,551, but not by pre-treatment with the selective β1-adrenoceptor antagonist, atenolol. In addition, application of albuterol, a selective β2-adrenoceptor agonist, significantly blocked capsaicin-evoked release of iCGRP. Collectively, these studies demonstrate that activation of β2-adrenoceptors in dental pulp significantly reduces exocytosis of neuropeptides from capsaicin-sensitive nociceptors. This effect may have physiologic significance in regulating PBF. Moreover, since capsaicin selectively activates nociceptors, β2-adrenoceptor agonists may have clinical utility as peripherally acting therapeutics for dental pain and inflammation.
Key Words: dental pulp superfusion CGRP capsaicin norepinephrine albuterol ICI 118 551 atenolol epinephrine
Journal of Dental Research, Vol. 82, No. 4,
308-311 (2003) This article has been cited by other articles:
|
||||||||||||||||
